203 related articles for article (PubMed ID: 12632246)
1. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.
Messa C; Colombo C; Moresco RM; Gobbo C; Galli L; Lucignani G; Gilardi MC; Rizzo G; Smeraldi E; Zanardi R; Artigas F; Fazio F
Psychopharmacology (Berl); 2003 Apr; 167(1):72-8. PubMed ID: 12632246
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study.
Moresco RM; Colombo C; Fazio F; Bonfanti A; Lucignani G; Messa C; Gobbo C; Galli L; Del Sole A; Lucca A; Smeraldi E
Neuroimage; 2000 Oct; 12(4):452-65. PubMed ID: 10988039
[TBL] [Abstract][Full Text] [Related]
3. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.
Meyer JH; Kapur S; Eisfeld B; Brown GM; Houle S; DaSilva J; Wilson AA; Rafi-Tari S; Mayberg HS; Kennedy SH
Am J Psychiatry; 2001 Jan; 158(1):78-85. PubMed ID: 11136637
[TBL] [Abstract][Full Text] [Related]
4. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study.
Zanardi R; Artigas F; Moresco R; Colombo C; Messa C; Gobbo C; Smeraldi E; Fazio F
J Clin Psychopharmacol; 2001 Feb; 21(1):53-8. PubMed ID: 11199948
[TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
[TBL] [Abstract][Full Text] [Related]
6. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.
Mintun MA; Sheline YI; Moerlein SM; Vlassenko AG; Huang Y; Snyder AZ
Biol Psychiatry; 2004 Feb; 55(3):217-24. PubMed ID: 14744461
[TBL] [Abstract][Full Text] [Related]
7. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
[TBL] [Abstract][Full Text] [Related]
8. Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride.
Montgomery AJ; Stokes P; Kitamura Y; Grasby PM
J Affect Disord; 2007 Aug; 101(1-3):113-22. PubMed ID: 17197036
[TBL] [Abstract][Full Text] [Related]
9. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.
Klimke A; Larisch R; Janz A; Vosberg H; Müller-Gärtner HW; Gaebel W
Psychiatry Res; 1999 Apr; 90(2):91-101. PubMed ID: 10482381
[TBL] [Abstract][Full Text] [Related]
11. In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study.
Moresco FM; Dieci M; Vita A; Messa C; Gobbo C; Galli L; Rizzo G; Panzacchi A; De Peri L; Invernizzi G; Fazio F
Neuroimage; 2002 Nov; 17(3):1470-8. PubMed ID: 12414286
[TBL] [Abstract][Full Text] [Related]
12. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos.
Figueras G; Pérez V; San Martino O; Alvarez E; Artigas F
Biol Psychiatry; 1999 Aug; 46(4):518-24. PubMed ID: 10459402
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study.
Praschak-Rieder N; Hussey D; Wilson AA; Carella A; Lee M; Dunn E; Willeit M; Bagby RM; Houle S; Meyer JH
Biol Psychiatry; 2004 Oct; 56(8):587-91. PubMed ID: 15476688
[TBL] [Abstract][Full Text] [Related]
15. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor.
Fujita M; Richards EM; Niciu MJ; Ionescu DF; Zoghbi SS; Hong J; Telu S; Hines CS; Pike VW; Zarate CA; Innis RB
Mol Psychiatry; 2017 May; 22(5):754-759. PubMed ID: 27725657
[TBL] [Abstract][Full Text] [Related]
16. Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.
Moresco RM; Cavallaro R; Messa C; Bravi D; Gobbo C; Galli L; Lucignani G; Colombo C; Rizzo G; Velonà I; Smeraldi E; Fazio F
J Psychopharmacol; 2004 Sep; 18(3):355-65. PubMed ID: 15358979
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects.
Wang GJ; Volkow ND; Logan J; Fowler JS; Schlyer D; MacGregor RR; Hitzemann RJ; Gur RC; Wolf AP
Life Sci; 1995; 56(14):PL249-53. PubMed ID: 7475891
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant medication exposure and 5-HT
Metts AV; Rubin-Falcone H; Ogden RT; Lin X; Wilner DE; Burke AK; Sublette ME; Oquendo MA; Miller JM; Mann JJ
Synapse; 2019 Jun; 73(6):e22089. PubMed ID: 30693567
[TBL] [Abstract][Full Text] [Related]
19. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
[TBL] [Abstract][Full Text] [Related]
20. Serotonin 1A receptor binding and treatment response in late-life depression.
Meltzer CC; Price JC; Mathis CA; Butters MA; Ziolko SK; Moses-Kolko E; Mazumdar S; Mulsant BH; Houck PR; Lopresti BJ; Weissfeld LA; Reynolds CF
Neuropsychopharmacology; 2004 Dec; 29(12):2258-65. PubMed ID: 15483563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
